ZAI Lab Limited, a novel drug development company located in Shanghai, broke out of stealth mode by announcing a major deal: the company has obtained global rights for two novel compounds from Sanofi (NYSE: SNY), both of which are potential treatments for chronic respiratory diseases (see story). ZAI is led by Dr. Samantha Du, who founded the company and serves as CEO. For ten years, Dr. Du was CEO of Hutchinson MediPharma, one of China’s very first innovative drug development companies. Since 2012, Dr. Du has been a Venture Partner at Sequoia Capital China.
Help employers find you! Check out all the jobs and post your resume.
